Revolution Medicines, Inc.
SHP2 INHIBITOR COMPOSITIONS AND METHODS FOR TREATING CANCER

Last updated:

Abstract:

The present disclosure provides methods of treating diseases or disorders related to mutations in the SHP2 gene using allosteric inhibitors of SHP2 and methods and diagnostic tests for identifying subjects susceptible or resistant to allosteric inhibitors of SHP2. In particular, the present disclosure provides allosteric inhibitor-sensitive mutations and allosteric inhibitor-resistant mutations of SHP2 for diagnostic and therapeutic use.

Status:
Application
Type:

Utility

Filling date:

6 Oct 2020

Issue date:

27 May 2021